Rand Paul Expects Hemp Bill This Week to Block Federal Criminalization

Sen. Rand Paul (R-KY) told constituents Tuesday he expects bipartisan legislation to hit Congress this week that would prevent federal recriminalization of hemp-derived THC products—a move he warned would be a "disaster" for the industry.

Speaking during an online town hall, Paul said the bill aims to head off regulatory changes set to take effect later this year that would effectively ban many hemp products currently sold legally across the country. The senator didn't provide specific details about the bill's sponsors or exact filing date, but emphasized the urgency of congressional action.

The looming threat stems from ongoing confusion around the 2018 Farm Bill's hemp provisions, which legalized hemp and its derivatives containing less than 0.3% delta-9 THC. But that law's language has created a gray area for products like delta-8 THC, delta-10, and other hemp-derived cannabinoids that have exploded in popularity—generating billions in sales through gas stations, convenience stores, and dedicated retailers.

The Regulatory Threat

Federal agencies have increasingly signaled they view many of these products as illegal, despite industry arguments that they fall within the Farm Bill's hemp definition. The Drug Enforcement Administration has issued guidance suggesting synthetic cannabinoids derived from hemp don't qualify for the legal exemption, while the Food and Drug Administration has cracked down on CBD products making health claims.

Paul, a longtime advocate for hemp farmers in Kentucky—one of the nation's top hemp-producing states—has consistently pushed back against what he sees as regulatory overreach. Kentucky farmers invested heavily in hemp production following the 2018 legalization, only to watch prices collapse as the CBD market became oversaturated. Many pivoted to producing biomass for hemp-derived THC products, viewing it as a lifeline.

The hemp industry has been bracing for stricter federal enforcement since last year, when lawmakers began discussing potential amendments to the Farm Bill that would tighten definitions around intoxicating hemp products. Several state legislatures have already moved to ban or heavily regulate delta-8 and similar compounds, creating a patchwork of conflicting laws.

Industry Stakes

Market analysts estimate the hemp-derived cannabinoid sector generated $2 billion to $3 billion in sales last year, with delta-8 THC products accounting for the bulk of revenue. The segment has provided a legal alternative in states without adult-use marijuana programs, though critics—including some cannabis industry groups—argue these products lack proper testing and age verification.

The bipartisan nature of Paul's expected bill could prove crucial. Hemp legalization has traditionally drawn support from both parties, with Republicans backing agricultural interests and Democrats supporting cannabis reform. But the rise of intoxicating hemp products has complicated that coalition, with some lawmakers viewing them as an end-run around state marijuana laws.

What's Next

If the bill materializes this week as Paul suggested, it will face a tight timeline. Congress is juggling multiple priorities including government funding deadlines and the broader Farm Bill reauthorization, which expired last year and is operating under an extension. Any hemp-specific legislation would likely need to be attached to a larger must-pass bill to gain traction.

Paul's office didn't immediately respond to requests for additional details about the bill's specific provisions or co-sponsors. Industry groups including the U.S. Hemp Roundtable have been lobbying intensively for legislative fixes that would provide clear legal pathways for hemp-derived products while addressing concerns about intoxicating compounds reaching minors.

The senator's warning about "disaster" reflects the stakes for thousands of hemp farmers, processors, and retailers who built businesses around products that could become federally illegal overnight without congressional intervention. For an industry that's already weathered boom-and-bust cycles since 2018, the regulatory uncertainty represents yet another existential threat.

This article is based on original reporting by www.marijuanamoment.net.